Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-012334

SVP & Chief Financial Officer sold 3,592 shares at $42.39 ($152,265)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2019-02-19 Sale −3,592 $42.39 $152,265 131,702 D
Open-market sales · 3,592 sh · avg $42.39 · $152,265
Loading xslF345X03/doc4.xml…